Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 39.89 USD 1.37% Market Closed
Market Cap: 7.4B USD
Have any thoughts about
Legend Biotech Corp?
Write Note

Gross Margin
Legend Biotech Corp

60.3%
Current
30%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60.3%
=
Gross Profit
274.9m
/
Revenue
456m

Gross Margin Across Competitors

Country US
Market Cap 7.4B USD
Gross Margin
60%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 300.2B USD
Gross Margin
67%
Country US
Market Cap 158.7B USD
Gross Margin
60%
Country US
Market Cap 126.8B USD
Gross Margin
86%
Country US
Market Cap 115B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 137.3B AUD
Gross Margin
52%
Country US
Market Cap 88.3B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.1B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for Legend Biotech Corp.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60.3%
=
Gross Profit
274.9m
/
Revenue
456m
What is the Gross Margin of Legend Biotech Corp?

Based on Legend Biotech Corp's most recent financial statements, the company has Gross Margin of 60.3%.